Sabra Health Care REIT, Inc. has entered into a new equity distribution agreement with a consortium of financial institutions, including major players such as Barclays Capital Inc., BMO Capital Markets Corp., and Morgan Stanley & Co. LLC. This agreement, established on August 5, 2025, allows for the sale of shares of the company's common stock, with proceeds intended for repaying debts, funding future investments, and general corporate purposes. The sales will be managed by the consortium, with an aggregate compensation for agents potentially reaching up to $11.25 million. The company also terminated a prior distribution agreement from February 2023 that allowed for up to $500 million in stock sales.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。